TXMD
Therapeuticsmd·NASDAQ
--
--(--)
--
--(--)
4.64 / 10
Netural
Fundamental scrutiny indicates a moderate standing with a score of 4.6/10. Key positives include a strong 94.6% year-over-year revenue growth and a healthy interest-coverage ratio of 15.5, both in performance group 2 or higher. However, negative factors such as a -68.4% net-profit-to-total-profit ratio and sub-par asset-to-market value weaken the picture. Overall, the fundamentals are solid but not outstanding, warranting a cautious view.
Analysis Checks(8/10)
Revenue-MV
Value-1.44
Score1/3
Weight8.01%
1M Return3.98%
Value-1.44
Score1/3
Weight8.01%
1M Return3.98%
Inventory turnover ratio
Value47.88
Score2/3
Weight-1.93%
1M Return-1.23%
Value47.88
Score2/3
Weight-1.93%
1M Return-1.23%
PB-ROE
Value-0.72
Score3/3
Weight26.76%
1M Return13.65%
Value-0.72
Score3/3
Weight26.76%
1M Return13.65%
Operating revenue (YoY growth rate %)
Value94.61
Score2/3
Weight0.17%
1M Return0.10%
Value94.61
Score2/3
Weight0.17%
1M Return0.10%
Net profit / Total profit (%)
Value-68.49
Score2/3
Weight-1.58%
1M Return-0.98%
Value-68.49
Score2/3
Weight-1.58%
1M Return-0.98%
Total operating revenue (YoY growth rate %)
Value94.61
Score3/3
Weight1.49%
1M Return0.88%
Value94.61
Score3/3
Weight1.49%
1M Return0.88%
Profit-MV
Value-2.09
Score2/3
Weight18.60%
1M Return8.99%
Value-2.09
Score2/3
Weight18.60%
1M Return8.99%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.51
Score2/3
Weight-2.01%
1M Return-1.25%
Value15.51
Score2/3
Weight-2.01%
1M Return-1.25%
Asset-MV
Value-0.51
Score1/3
Weight19.15%
1M Return8.68%
Value-0.51
Score1/3
Weight19.15%
1M Return8.68%
Cash-MV
Value0.22
Score3/3
Weight31.33%
1M Return12.04%
Value0.22
Score3/3
Weight31.33%
1M Return12.04%
Revenue-MV
Value-1.44
Score1/3
Weight8.01%
1M Return3.98%
Value-1.44
Score1/3
Weight8.01%
1M Return3.98%
Total operating revenue (YoY growth rate %)
Value94.61
Score3/3
Weight1.49%
1M Return0.88%
Value94.61
Score3/3
Weight1.49%
1M Return0.88%
Inventory turnover ratio
Value47.88
Score2/3
Weight-1.93%
1M Return-1.23%
Value47.88
Score2/3
Weight-1.93%
1M Return-1.23%
Profit-MV
Value-2.09
Score2/3
Weight18.60%
1M Return8.99%
Value-2.09
Score2/3
Weight18.60%
1M Return8.99%
PB-ROE
Value-0.72
Score3/3
Weight26.76%
1M Return13.65%
Value-0.72
Score3/3
Weight26.76%
1M Return13.65%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.51
Score2/3
Weight-2.01%
1M Return-1.25%
Value15.51
Score2/3
Weight-2.01%
1M Return-1.25%
Operating revenue (YoY growth rate %)
Value94.61
Score2/3
Weight0.17%
1M Return0.10%
Value94.61
Score2/3
Weight0.17%
1M Return0.10%
Asset-MV
Value-0.51
Score1/3
Weight19.15%
1M Return8.68%
Value-0.51
Score1/3
Weight19.15%
1M Return8.68%
Net profit / Total profit (%)
Value-68.49
Score2/3
Weight-1.58%
1M Return-0.98%
Value-68.49
Score2/3
Weight-1.58%
1M Return-0.98%
Cash-MV
Value0.22
Score3/3
Weight31.33%
1M Return12.04%
Value0.22
Score3/3
Weight31.33%
1M Return12.04%
Is TXMD undervalued or overvalued?
- TXMD scores 4.64/10 on fundamentals and holds a Fair valuation at present. Backed by its 0.18% ROE, 10.80% net margin, -57.75 P/E ratio, 0.97 P/B ratio, and 110.71% earnings growth, these metrics solidify its Netural investment rating.
